Delirium incidence and risk factors in patients undergoing non-invasive ventilation for acute respiratory failure: a multicenter observational trial.


Journal

Minerva anestesiologica
ISSN: 1827-1596
Titre abrégé: Minerva Anestesiol
Pays: Italy
ID NLM: 0375272

Informations de publication

Date de publication:
10 2022
Historique:
pubmed: 17 6 2022
medline: 20 10 2022
entrez: 16 6 2022
Statut: ppublish

Résumé

Noninvasive ventilation (NIV) still has high failure rate when used for de novo acute respiratory failure (ARF). Delirium may impact the outcome, however data regarding its incidence, timing of occurrence and clinical predictors in this subset of patients are scarce. Consecutive patients with de novo ARF subjected to NIV were recruited in 10 Italian Respiratory Intensive Care Units (RICUs) and Intensive Care Units (ICUs). Demographics and clinical features, including tolerance to interface and NIV setting were recorded on admission and during stay, whereas delirium onset and type was assessed by the Confusion Assessment Method for ICU (CAM-ICU)-7 scale and Richmond Agitation Sedation Scale (RASS) twice/per day up to a week. The association between clinical variables and the occurrence of delirium and its influence on NIV failure and other clinical outcomes were analyzed. Thirty-two out of 90 enrolled patients (36%) developed delirium over seven days upon admission; median time to onset was 48 hours (24-60). Older age (OR=2.7 [1.9-9], P=0.01), the presence of cancer OR=3.7 [2-5.4], P=0.002), sepsis (OR=1.7 [1.1-3.4], P=0.01), SOFA Score (OR=1.8 [1.1-3.1], P=0.01), low tolerance to interface (OR=3.2 [2.1-5], P=0.002), use of helmet (OR=1.9 [1.2-4.3] P=0.04), and higher PRE-DELIRIC (OR=3.5 [1.3-15], P=0.03) and BORG (OR=1.7 [1.1-4.6], P=0.02] scores were significantly associated with delirium. Delirium had high risk for NIV failure (HR=3.5 95% CI: [1.4-8.6], P=0.0002) and it significantly associated with longer RICU/ICU stay and higher mortality. Delirium onset in acute hypoxic patients undergoing NIV is frequent and negatively affects the outcome. Multiple related clinical factors should be addressed early on admission to prevent the delirium-related risk of NIV failure in these patients.

Sections du résumé

BACKGROUND
Noninvasive ventilation (NIV) still has high failure rate when used for de novo acute respiratory failure (ARF). Delirium may impact the outcome, however data regarding its incidence, timing of occurrence and clinical predictors in this subset of patients are scarce.
METHODS
Consecutive patients with de novo ARF subjected to NIV were recruited in 10 Italian Respiratory Intensive Care Units (RICUs) and Intensive Care Units (ICUs). Demographics and clinical features, including tolerance to interface and NIV setting were recorded on admission and during stay, whereas delirium onset and type was assessed by the Confusion Assessment Method for ICU (CAM-ICU)-7 scale and Richmond Agitation Sedation Scale (RASS) twice/per day up to a week. The association between clinical variables and the occurrence of delirium and its influence on NIV failure and other clinical outcomes were analyzed.
RESULTS
Thirty-two out of 90 enrolled patients (36%) developed delirium over seven days upon admission; median time to onset was 48 hours (24-60). Older age (OR=2.7 [1.9-9], P=0.01), the presence of cancer OR=3.7 [2-5.4], P=0.002), sepsis (OR=1.7 [1.1-3.4], P=0.01), SOFA Score (OR=1.8 [1.1-3.1], P=0.01), low tolerance to interface (OR=3.2 [2.1-5], P=0.002), use of helmet (OR=1.9 [1.2-4.3] P=0.04), and higher PRE-DELIRIC (OR=3.5 [1.3-15], P=0.03) and BORG (OR=1.7 [1.1-4.6], P=0.02] scores were significantly associated with delirium. Delirium had high risk for NIV failure (HR=3.5 95% CI: [1.4-8.6], P=0.0002) and it significantly associated with longer RICU/ICU stay and higher mortality.
CONCLUSIONS
Delirium onset in acute hypoxic patients undergoing NIV is frequent and negatively affects the outcome. Multiple related clinical factors should be addressed early on admission to prevent the delirium-related risk of NIV failure in these patients.

Identifiants

pubmed: 35708040
pii: S0375-9393.22.16511-9
doi: 10.23736/S0375-9393.22.16511-9
doi:

Types de publication

Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

815-826

Investigateurs

Alessandro Andreani (A)
Dario Andrisani (D)
Serena Baroncini (S)
Bianca Beghè (B)
Lucio Bonazza (L)
Elisa Boni (E)
Giulia Bruzzi (G)
Michele Cacciapaglia (M)
Gaia Cappiello (G)
Ivana Castaniere (I)
Caterina Cerbone (C)
Enrico Clini (E)
Vittoria Comellini (V)
Roberto Dongilli (R)
Pierluigi Donatelli (P)
Vinicio Danzi (V)
Riccardo Fantini (R)
Laura Falsini (L)
Marco Feri (M)
Filippo Gozzi (F)
Linda Manicardi (L)
Alessandro Marchioni (A)
Enrico Marin (E)
Rosita Melara (R)
Antonio Moretti (A)
Chiara Nani (C)
Stefano Nava (S)
Maria C Paonessa (MC)
Giustino Parruti (G)
Lara Pisani (L)
Beniamino Praticò (B)
Viviana Ribuffo (V)
Marianna Sacchi (M)
Sara Sorgentone (S)
Antonella Spacone (A)
Luca Tabbì (L)
Roberto Tonelli (R)
Fabiana Trentacosti (F)
Morgana Vermi (M)

Auteurs

Luca Tabbì (L)

Unit of Respiratory Diseases, Department of Medical and Surgical Sciences, University Hospital of Modena, University of Modena-Reggio Emilia, Modena, Italy.

Roberto Tonelli (R)

Unit of Respiratory Diseases, Department of Medical and Surgical Sciences, University Hospital of Modena, University of Modena-Reggio Emilia, Modena, Italy - roberto.tonelli@me.com.
Department of Clinical and Experimental Medicine, University of Modena Reggio Emilia, Modena, Italy.

Vittoria Comellini (V)

Department of Specialistic, Diagnostic and Experimental Medicine (DIMES), University of Bologna, Bologna, Italy.

Roberto Dongilli (R)

Unit of Semi-Intensive Respiratory Therapy, Department of Pneumology, Azienda Sanitaria dell'Alto Adige, Comprensorio Sanitario di Bolzano, Hospital Bolzano, Bolzano, Italy.

Sara Sorgentone (S)

Unit of Medicine, San Liberatore Hospital, Atri, Teramo, Italy.

Antonella Spacone (A)

Unit of Pneumology and Respiratory Physiopathology, Santo Spirito Hospital, Pescara, Italy.

Maria C Paonessa (MC)

Unit of Semi-Intensive Therapy, Unit of Internal Medicine, M. Bufalini Hospital, Cesena, Forlì-Cesena, Italy.

Marianna Sacchi (M)

Intensive Care and Resuscitation Unit, Presidio Ospedaliero Santissima Annunziata, Taranto, Italy.

Laura Falsini (L)

Intensive Care and Resuscitation Unit, San Donato Hospital, Arezzo, Italy.

Elisa Boni (E)

Intensive Care and Resuscitation Unit, San Bortolo Hospital, Vicenza, Italy.

Viviana Ribuffo (V)

Unit of Pneumology, Santa Maria Bianca Hospital, Mirandola, Modena, Italy.

Giulia Bruzzi (G)

Unit of Respiratory Diseases, Department of Medical and Surgical Sciences, University Hospital of Modena, University of Modena-Reggio Emilia, Modena, Italy.

Ivana Castaniere (I)

Unit of Respiratory Diseases, Department of Medical and Surgical Sciences, University Hospital of Modena, University of Modena-Reggio Emilia, Modena, Italy.
Department of Clinical and Experimental Medicine, University of Modena Reggio Emilia, Modena, Italy.

Riccardo Fantini (R)

Unit of Respiratory Diseases, Department of Medical and Surgical Sciences, University Hospital of Modena, University of Modena-Reggio Emilia, Modena, Italy.

Alessandro Marchioni (A)

Unit of Respiratory Diseases, Department of Medical and Surgical Sciences, University Hospital of Modena, University of Modena-Reggio Emilia, Modena, Italy.

Lara Pisani (L)

Department of Specialistic, Diagnostic and Experimental Medicine (DIMES), University of Bologna, Bologna, Italy.

Stefano Nava (S)

Department of Specialistic, Diagnostic and Experimental Medicine (DIMES), University of Bologna, Bologna, Italy.

Enrico Clini (E)

Unit of Respiratory Diseases, Department of Medical and Surgical Sciences, University Hospital of Modena, University of Modena-Reggio Emilia, Modena, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH